Ahn S, Chantre CO, Ardona HAM, et al
Although this study was limited by its retrospective design with a small number of samples, Korean patients with PFPT from our institute have showed the tendency of following characteristics: (1) female predominance, (2) more common in ages between 20~49 years, and (3) high prevalence of concomitant pigmentary disorders
The recommended dosing for acetyl-L-carnitine typically ranges from 500 to 2,000 milligrams daily, divided into two or three doses
1,2 Cutaneous reactions are the most frequent, with maculopapular exanthemas being the most common type
Pre-Research Assessment: Complete medical history and physical review Baseline blood glucose and HbA1c Liver function tests (ALT, AST, bilirubin) Renal function tests (creatinine, BUN, eGFR) Complete blood count Lipid panel IGF-1 and IGFBP-3 levels Thyroid function tests Screening for contraindications During Research Tracking: Regular blood glucose tracking (frequency based on dose and risk factors) Periodic assessment of liver and renal function Tracking for signs of fluid retention Assessment of injection sites Records of any adverse findings Regular evaluation of research parameters Post-Research Assessment: Repeat baseline laboratory tests Evaluation of any persistent effects Assessment of research outcomes Planning of appropriate follow-up Managing Adverse Observations Research protocols should include plans for managing possible adverse findings